[Federal Register Volume 81, Number 154 (Wednesday, August 10, 2016)]
[Notices]
[Pages 52908-52909]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-18921]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Registrants listed below have applied for and been granted 
registration by-the Drug Enforcement Administration (DEA) as bulk 
manufacturers of various classes of controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be 
registered as manufacturers of various basic classes of controlled 
substances. Information on previously published notices is listed in 
the table below. No comments or objections were submitted for these 
notices.

[[Page 52909]]



------------------------------------------------------------------------
             Company                   FR Docket           Published
------------------------------------------------------------------------
Noramco, Inc....................  81 FR 7587........  February 12, 2016.
Cayman Chemical Company.........  81 FR 9217........  February 24, 2016.
Janssen Pharmaceutical, Inc.....  81 FR 9219........  February 24, 2016.
Insys Therapeutics, Inc.........  81 FR 9220........  February 24, 2016.
Siemens Healthcare Diagnostics,   81 FR 15565.......  March 23, 2016.
 Inc..
Siegfried USA, LLC..............  81 FR 15567.......  March 23, 2016.
Patheon Pharmaceuticals, Inc....  81 FR 15571.......  March 23, 2016.
Navinta, LLC....................  81 FR 20418.......  April 7, 2016.
Patheon API Manufacturing, Inc..  81 FR 22122.......  April 14, 2016.
------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of these registrants to manufacture 
the applicable basic classes of controlled substances is consistent 
with the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated each of the company's maintenance of 
effective controls against diversion by inspecting and testing each 
company's physical security systems, verifying each company's 
compliance with state and local laws, and reviewing each company's 
background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer 
to the above listed persons.

    Dated: August 2, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-18921 Filed 8-9-16; 8:45 am]
 BILLING CODE 4410-09-P